Dystonic DisordersBotulinum Toxins, Type ABotulinum ToxinsNeuromuscular AgentsDystoniaClostridium botulinumAnti-Dyskinesia AgentsTorticollisBlepharospasmBotulismInjections, IntramuscularInjectionsBotulinum AntitoxinMuscle SpasticitySpasmAthetosisMeige SyndromeSialorrheaTetanus ToxinChoreaHandwritingFissure in AnoInfusions, SpinalClostridium botulinum type AClostridium botulinum type ECholera ToxinDystonia Musculorum DeformansHyperhidrosisCerebral PalsyNeurotoxinsNeck MusclesHemifacial SpasmEsophageal AchalasiaFacial MusclesMovement DisordersT-2 ToxinInjections, IntralesionalSweating, GustatoryBipolar DisorderSynaptosomal-Associated Protein 25Treatment OutcomeElectromyographyTremorMuscle CrampMetoclopramideToxins, BiologicalGlobus PallidusMental DisordersOculomotor MusclesInjections, IntradermalAntitoxinsUrinary Bladder, OveractiveEntopeduncular NucleusHarmalineAnxiety DisordersEquinus DeformityMood DisordersRejuvenationClostridium botulinum type BCosmetic TechniquesSkin AgingRats, Mutant StrainsNeuromuscular JunctionToxoidsVoice DisordersClostridium botulinum type FParalysisLethal Dose 50Neuromuscular Blocking AgentsHandClostridium botulinum type DMarine ToxinsInjections, IntravenousBasal GangliaR-SNARE ProteinsManometryTime FactorsDiagnostic and Statistical Manual of Mental DisordersADP Ribose TransferasesBromisovalumFood MicrobiologyMeliaSphincter of OddiHemiplegiaMyoclonusDose-Response Relationship, DrugStrabismusMuscle HypertoniaShiga ToxinsFacial NerveUpper ExtremitySynkinesisGastroparesisDisease Models, AnimalMuscle DenervationCholinergic AntagonistsMuscle Relaxants, CentralShiga Toxin 2Biological AssayInjections, Subcutaneous